Literature DB >> 28687977

Invasive mucinous adenocarcinoma with lepidic-predominant pattern coexisted with tuberculosis: a case report.

Xinxin Xu1, Yinshi Guo2, Qiuying Li3, Ling Yang4, Jianqiang Kang1.   

Abstract

We observed a rare case of invasive mucinous adenocarcinoma (IMA) with a lepidic-predominant pattern accompanied by pulmonary tuberculosis. An 85-year-old man with repeated cough and sputum was admitted to Xinhua Hospital. T-SPOT test result was 212 pg/ml (reference value of negative is < 14 pg/ml), Mycobacterium tuberculosis culture was positive, and tuberculin skin test (PPD) was negative (skin induration < 5 mm). The patient was treated with several courses of antibiotics and anti-tuberculosis treatments. Repeated chest CT scans showed disease progression. Bronchoscopy yielded negative results. PET-CT scans showed negative results. A percutaneous lung biopsy revealed mucin-secreting cells lining the alveolar walls. IMA with a lepidic-predominant pattern was diagnosed after invasiveness was found after experimental treatments. Simultaneous occurrence of pulmonary tuberculosis and lung cancer are common; however, the present case of IMA having a lepidic-predominant pattern and coexisting with active tuberculosis has not been reported yet.

Entities:  

Keywords:  invasive mucinous adenocarcinoma; lepidic-predominant; tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 28687977     DOI: 10.1007/s11684-017-0545-4

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  14 in total

Review 1.  Tuberculosis and malignancy.

Authors:  M E Falagas; V D Kouranos; Z Athanassa; P Kopterides
Journal:  QJM       Date:  2010-05-26

2.  Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.

Authors:  Sona Balogova; Virginie Huchet; Khaldoun Kerrou; Valerie Nataf; Fabrice Gutman; Martine Antoine; Anne-Marie Ruppert; Aurélie Prignon; Armelle Lavolée; Francoise Montravers; Charles Mayaud; Jacques Cadranel; Jean-Noël Talbot
Journal:  Nucl Med Commun       Date:  2010-05       Impact factor: 1.690

3.  Primary lung cancer coexisting with active pulmonary tuberculosis.

Authors:  Y Varol; U Varol; M Unlu; I Kayaalp; A Ayranci; M S Dereli; S Z Guclu
Journal:  Int J Tuberc Lung Dis       Date:  2014-09       Impact factor: 2.373

Review 4.  Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings.

Authors:  K S Lee; Y Kim; J Han; E J Ko; C K Park; S L Primack
Journal:  Radiographics       Date:  1997 Nov-Dec       Impact factor: 5.333

5.  Invasive mucinous adenocarcinoma mimicking organizing pneumonia associated with Mycobacterium fortuitum infection.

Authors:  Daisuke Morichika; Nobuaki Miyahara; Katsuyuki Hotta; Yoshiko Okamoto; Daisuke Minami; Masahiro Irie; Yasushi Tanimoto; Arihiko Kanehiro; Mitsune Tanimoto; Katsuyuki Kiura
Journal:  Intern Med       Date:  2014-12-15       Impact factor: 1.271

6.  Coexisting bronchogenic carcinoma and pulmonary tuberculosis in the same lobe: radiologic findings and clinical significance.

Authors:  Y I Kim; J M Goo; H Y Kim; J W Song; J G Im
Journal:  Korean J Radiol       Date:  2001 Jul-Sep       Impact factor: 3.500

Review 7.  Pictorial review of the many faces of bronchioloalveolar cell carcinoma.

Authors:  D Patsios; H C Roberts; N S Paul; T Chung; S J Herman; A Pereira; G Weisbrod
Journal:  Br J Radiol       Date:  2007-10-16       Impact factor: 3.039

8.  The clinical course of respiratory tuberculosis in lung cancer patients.

Authors:  S-I Cha; K-M Shin; J-W Lee; S-Y Lee; C-H Kim; J-Y Park; T-H Jung
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 2.373

Review 9.  Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.

Authors:  Darren R Brenner; John R McLaughlin; Rayjean J Hung
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

10.  Lung cancer in patients with tuberculosis.

Authors:  Saulius Cicenas; Vladislavas Vencevicius
Journal:  World J Surg Oncol       Date:  2007-02-19       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.